NCT02697123

Brief Summary

The purpose of the study is to prospectively assess the prevalence of venous thrombosis in women hospitalized for Cesarean Section, vaginal delivery or extended antepartum hospitalization by using Compression ultrasound of the entire proximal venous system of the lower limb veins.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

February 25, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

January 15, 2025

Status Verified

December 1, 2024

Enrollment Period

3.5 years

First QC Date

February 25, 2016

Last Update Submit

January 13, 2025

Conditions

Keywords

Venous ThrombosisPregnancypostpartumantepartum

Outcome Measures

Primary Outcomes (1)

  • incidence of Venous Thrombosis in patients hospitalized for Cesarean Section, Vaginal delivery or any antepartum indication

    48 hours (plus or minus 24 hours) after delivery.

Study Arms (1)

antepartum and postpartum

This prospective, observational cohort study was designed to assess the incidence of VTE in patients hospitalized for Cesarean Section, Vaginal delivery or any antepartum indication.

Other: antepartum and postpartum

Interventions

This is a prospective observational cohort study.

antepartum and postpartum

Eligibility Criteria

Age18 Years - 64 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All patients presenting to TCH/Women's Pavilion and Ben Taub Hospital for Cesarean Section, vaginal delivery or any antepartum hospitalization will considered for the study.

You may qualify if:

  • All patients hospitalized for Cesarean Section,
  • All patients hospitalized for vaginal delivery
  • any other antepartum indication of hospitalization.

You may not qualify if:

  • Psychiatric illness
  • social situations that could limit compliance with study activities
  • all patients who lack capacity to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Venous Thrombosis

Interventions

Postpartum Period

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Reproductive Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Officials

  • Steven L Clark, M.D.

    Baylor College of Medicine

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair

Study Record Dates

First Submitted

February 25, 2016

First Posted

March 3, 2016

Study Start

February 1, 2016

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

January 15, 2025

Record last verified: 2024-12

Locations